Wijsman E M
Department of Medicine, University of Washington, Seattle 98195.
Am J Hum Genet. 1991 Apr;48(4):654-61.
Extensions to models originally described by Hartl for predicting the recurrence risk of new dominant mutations are developed in this paper. Additions to the models are (1) possible somatic mosaicism in a parent in some families, (2) the possibility that the parental origin of the mutation may or may not be known, and (3) mutation rates which change as a function of sex and/or time. The models indicate that recurrence risks are most critically affected by (a) the amount of somatic mosaicism which can be tolerated in the parent without manifesting disease and (b) knowledge of the parental origin of the mutation. In addition, there is a moderate effect on recurrence risks if mutation rates increase in the father as a function of time. Recurrence risks are at least as large as the risk of trisomy 21 in a child of a mother of age 35 years or older, probably much higher (5%-10%) when the mutation is known to be of maternal origin or if substantial somatic mosaicism in the parent is compatible with a normal phenotype. The recurrence risk of a new mutation is high because of a very high ascertainment bias of families with substantial germ-line mosaicism.
本文对最初由哈特尔描述的用于预测新显性突变复发风险的模型进行了扩展。模型的新增内容包括:(1)某些家族中父母一方可能存在体细胞镶嵌现象;(2)突变的亲本来源可能已知也可能未知;(3)突变率随性别和/或时间变化。模型表明,复发风险最关键地受到以下因素影响:(a)父母一方在不表现出疾病的情况下可耐受的体细胞镶嵌量;(b)突变的亲本来源的知识。此外,如果父亲的突变率随时间增加,对复发风险有中等程度的影响。复发风险至少与35岁及以上母亲生育的孩子患21三体综合征的风险一样大,当已知突变来自母亲或父母一方存在大量体细胞镶嵌且与正常表型相符时,复发风险可能更高(5%-10%)。由于具有大量生殖系镶嵌现象的家族的确诊偏倚非常高,新突变的复发风险很高。